首页 | 官方网站   微博 | 高级检索  
     

骨疏康胶囊联合利塞膦酸钠治疗绝经后骨质疏松症的临床研究
引用本文:周雪红,刘曙艳,林彦杰.骨疏康胶囊联合利塞膦酸钠治疗绝经后骨质疏松症的临床研究[J].现代药物与临床,2020,35(9):1821-1825.
作者姓名:周雪红  刘曙艳  林彦杰
作者单位:北京中医药大学中药学院 中药炮制系, 北京 102488;北京中医药大学中药学院 中药现代研究中心, 北京 100029;北京同仁堂科技发展股份有限公司制药厂, 北京 100079
基金项目:北京市中药炮制技术传承基地建设项目
摘    要:目的 比较黄芩酒炙前后化学成分变化,为建立全面的黄芩饮片质量评价方法提供参考。方法 HPLC法建立黄芩片、酒黄芩的特征图谱,并生成对照特征图谱,标定共有峰并进行相似度评价。采用UPLC-Q-TOF/MS定性分析黄芩酒炙前后化学成分,利用UPLC-TQMS对2种饮片中11种黄酮类成分(黄芩苷、黄芩素、汉黄芩苷、汉黄芩素、千层纸素A、千层纸苷、野黄芩苷、芹菜素、高车前素、木犀草苷、白杨素)进行定量分析,并以含量为变量进行多元统计分析。结果 建立了黄芩片、酒黄芩的特征图谱,标定9个共有峰,2种饮片相似度均在0.947以上。在黄芩饮片中,共发现50种成分,通过多级质谱数据分析,保留时间匹配,并结合对照品及数据库检索,鉴定了其中44种成分。UPLC-TQMS定量结果显示酒炙后黄芩中黄芩苷、汉黄芩苷等黄酮苷类成分含量略有下降,黄芩素、汉黄芩素等黄酮苷元类成分含量稍有增加。经多元统计学分析,2种饮片有明显的分离趋势,载荷图结果表明黄芩苷、汉黄芩苷、千层纸苷的含量差异可能是引起黄芩酒炙前后化学成分变化的主要因素。结论 黄芩酒炙后没有新增或消失成分,但成分含量有所变化。所建立黄芩饮片的定性、定量方法重现性好,分析快速、准确,可用于黄芩饮片酒炙前后的质量评价。

关 键 词:黄芩  酒黄芩  HPLC  特征图谱  UPLC-Q-TOF/MS  UPLC-TQMS  化学成分组  多元统计学分析  质量评价  相似度评价  黄芩苷  黄芩素  汉黄芩苷  汉黄芩素  千层纸素A  千层纸苷  野黄芩苷  芹菜素  高车前素  木犀草苷  白杨素
收稿时间:2019/11/18 0:00:00

Clinical study on Gushukang Capsules combined with risedronate sodium in treatment of postmenopausal osteoporosis
ZHOU Xue-hong,LIU Shu-yan,LIN Yan-jie.Clinical study on Gushukang Capsules combined with risedronate sodium in treatment of postmenopausal osteoporosis[J].Drugs & Clinic,2020,35(9):1821-1825.
Authors:ZHOU Xue-hong  LIU Shu-yan  LIN Yan-jie
Affiliation:Department of Chinese Meteria Medicine Processing, School of Chinese Meteria Medicine, Beijing University of Chinese Medicine, Beijing 102488, China;Modern Research Center for Traditional Chinese Medicine, School of Chinese Meteria Medica, Beijing University of Chinese Medicine, Beijing 100029, China;Pharmaceutical Factory, Beijing Tongrentang Science and Technology Co., Ltd., Beijing 100079, China
Abstract:Objective To compare the chemical compositions of Scutellariae Radix (SR) before and after wine-frying, and provide a reference for establishing a comprehensive quality evaluation method for SR decoction pieces. Methods Characteristic chromatogram of SR and wine-processed Scutellariae Radix (wpSR) were established using HPLC, the control characteristic chromatogram maps were generated, the common peaks were calibrated and the similarity was evaluated. Chemical compositions of SR and wpSR were identified by UPLC-Q-TOF/MS. The content profiles of 11 flavonoids (baicalin, baicalein, wogonoside, wogonin, oroxylin A, oroxyloside, scutellarin, apigenin, hispidulin, luteoloside and chrysin) of SR and wpSR was determined by UPLC-TQMS, and PCA was used to analysis the content of 11 flavonoids. Results The characteristic chromatogram of SR and wpSR were established, and nine common peaks were calibrated. The similarity of two pieces were all greater than 0.947. Through the analysis of the multistage tandem mass spectrometry, retention time matching combined with the software of database search and literatures, 50 compositions were found and 44 compositions were identified in two pieces. The quantitative results showed that the content of flavonoid glycosides such as baicalin and wogonoside decreased slightly, while the content of flavonoid aglycones such as baicalein and wogonin increased slightly. After multivariate statistical analysis, two pieces were divided into two types. The differences of the content of baicalin, wogonoside and oroxyloside may be the main factors causing the change of chemical compositions of wine-frying of SR. Conclusion Chemical profiles did not change after wine-frying of SR, but the content profiles of some compositions were changed. The established method can provide reproducible, efficient, as well as accurate analysis for Chinese medicinal materials. And it should be an eligible tool for the quality evaluation of SR.
Keywords:Scutellariae Radix  wine-processed Scutellar iae Radix  HPLC  characteristic chromatogram  UPLC-Q-TOF/MS  UPLC-TQMS  chemical compositions  multivariate statistical analysis  quality evaluation  similarity evaluation  baicalin  baicalein  wogonoside  wogonin  oroxylin A  oroxyloside  scutellarin  apigenin  hispidulin  luteoloside  chrysin
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号